John Barton is a professor emeritus at the Stanford Law School, an FSI senior fellow by courtesy, and a CHP/PCOR associate. His research and publications focus on international scientific research and cooperation, the relationship between intellectual property and antitrust, and the transfer of technology -- particularly vaccine production technology -- to developing countries. Barton has recently published an article in the Journal of the American Medical Association on the pharmaceutical development process, and is co-author of the product development priorities chapter in the forthcoming book Disease Control Priorities in Developing Countries. He has participated extensively in discussions regarding drug access for developing nations. He is also interested in the marketing structure of the pharmaceutical industry and the impact of vaccine regulation on the structure of the international vaccine industry.